Cite
MLA Citation
Jessica R. Allegretti et al.. “S145 Week 24 Efficacy and Safety Data from PRISM3: A Randomized, Placebo-Controlled Trial Evaluating CP101, an Investigational Orally Administered Microbiome Therapeutic for the Prevention of Recurrent C. difficile Infection.” American journal of gastroenterology, vol. 116, n.d., pp. S63–S64. http://access.bl.uk/ark:/81055/vdc_100144524452.0x00004b